Delivery Order SPE2DB20D3103-SPE2DB25FQ3E5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,094.91 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. Mounjaro is a diabetes management medication, consistent with AmerisourceBergen's established...
- The Defense Logistics Agency awarded a delivery order valued at $43,363.77 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pen injectors on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes treatment medication, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $8,984.96 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors on November 17, 2025, with completion expected by November 18, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,162.70 for Mounjaro 7.5 mg/0.5 ml pen auto-injectors on July 23, 2025, with completion targeted for July 24, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, representing part of the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,607.06 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on July 18, 2025, with completion scheduled for July 21, 2025. This firm fixed price delivery order represents a non-competitive award and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control and weight management within military and federal...
- The Defense Logistics Agency awarded a $2,777.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on September 8, 2025, with completion targeted for September 9, 2025. This delivery order, issued without a set-aside designation, represents a competitive award under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $9,747.92 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injectables on October 30, 2025, with an ultimate completion date of October 31, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a prescription medication used in diabetes management, consistent with...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors valued at $18,305.89 on October 29, 2025, with completion scheduled for October 30, 2025. This competitive award, which carries no set-aside designation, utilizes a firm fixed-price delivery order structure and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for managing type...
- The Defense Logistics Agency awarded a delivery order valued at $8,444.80 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injectors on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, aligning with...
- The Defense Logistics Agency awarded a delivery order valued at $3,057.94 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes treatment medication, consistent with AmerisourceBergen's extensive...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3E5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,575.10 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on September 16, 2025, with completion targeted for September 17, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control and weight management, reflecting the Defense Logistics Agency's ongoing pharmaceutical supply requirements for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support Defense Health Agency and military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates the company's established capability to fulfill federal procurement requirements through competitive awards and to manage high-volume pharmaceutical distribution across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 9/16/25 |